These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 3931522

  • 1. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.
    Mendelman PM, Smith AL, Levy J, Weber A, Ramsey B, Davis RL.
    Am Rev Respir Dis; 1985 Oct; 132(4):761-5. PubMed ID: 3931522
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
    Ratjen F, Döring G, Nikolaizik WH.
    Lancet; 2001 Sep 22; 358(9286):983-4. PubMed ID: 11583754
    [Abstract] [Full Text] [Related]

  • 6. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev-K M, Borowitz D, Bowman CM, Marshall BC, Marshall S, Smith AL.
    N Engl J Med; 1999 Jan 07; 340(1):23-30. PubMed ID: 9878641
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F, Trivier D, Vic P, Ategbo S, Turck D, Husson MO.
    Pathol Biol (Paris); 1998 Jun 07; 46(6):449-51. PubMed ID: 9769880
    [Abstract] [Full Text] [Related]

  • 10. Eradication of Pseudomonas aeruginosa in an adult patient with cystic fibrosis.
    Hayes D, Feola DJ, Murphy BS, Kuhn RJ, Davis GA.
    Am J Health Syst Pharm; 2011 Feb 15; 68(4):319-22. PubMed ID: 21289326
    [Abstract] [Full Text] [Related]

  • 11. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone.
    Regelmann WE, Elliott GR, Warwick WJ, Clawson CC.
    Am Rev Respir Dis; 1990 Apr 15; 141(4 Pt 1):914-21. PubMed ID: 2109558
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG, Gembitskaia TE.
    Ter Arkh; 2010 Apr 15; 82(8):76-8. PubMed ID: 20873251
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa.
    Alipour M, Suntres ZE, Omri A.
    J Antimicrob Chemother; 2009 Aug 15; 64(2):317-25. PubMed ID: 19465435
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis.
    Geller DE, Pitlick WH, Nardella PA, Tracewell WG, Ramsey BW.
    Chest; 2002 Jul 15; 122(1):219-26. PubMed ID: 12114362
    [Abstract] [Full Text] [Related]

  • 17. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.
    Burns JL, Van Dalfsen JM, Shawar RM, Otto KL, Garber RL, Quan JM, Montgomery AB, Albers GM, Ramsey BW, Smith AL.
    J Infect Dis; 1999 May 15; 179(5):1190-6. PubMed ID: 10191222
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamics of tobramycin in patients with cystic fibrosis.
    Mouton JW, Jacobs N, Tiddens H, Horrevorts AM.
    Diagn Microbiol Infect Dis; 2005 Jun 15; 52(2):123-7. PubMed ID: 15964500
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputum.
    Ramphal R, Lhermitte M, Filliat M, Roussel P.
    J Antimicrob Chemother; 1988 Oct 15; 22(4):483-90. PubMed ID: 3060459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.